Burman WJ - Search Results

1

The case for conservative management of early HIV disease.

Burman WJ, Reves RR, Cohn DL. Burman WJ, et al. JAMA. 1998 Jul 1;280(1):93-5. doi: 10.1001/jama.280.1.93. JAMA. 1998. PMID: 9660372 No abstract available.

2

Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.

Burman WJ, Breese PE, Murray BE, Singh KV, Batal HA, MacKenzie TD, Ogle JW, Wilson ML, Reves RR, Mehler PS. Burman WJ, et al. Am J Med. 2003 Oct 1;115(5):358-64. doi: 10.1016/s0002-9343(03)00372-3. Am J Med. 2003. PMID: 14553870

3

Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings.

Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ. Jenkins TC, et al. Among authors: burman wj. Sex Transm Dis. 2006 May;33(5):329-33. doi: 10.1097/01.olq.0000194617.91454.3f. Sex Transm Dis. 2006. PMID: 16547450

4

HIV transmission risk behavior and its relation to antiretroviral treatment adherence.

Flaks RC, Burman WJ, Gourley PJ, Rietmeijer CA, Cohn DL. Flaks RC, et al. Among authors: burman wj. Sex Transm Dis. 2003 May;30(5):399-404. doi: 10.1097/00007435-200305000-00005. Sex Transm Dis. 2003. PMID: 12916130

5

Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial.

Burman W, Grund B, Neuhaus J, Douglas J Jr, Friedland G, Telzak E, Colebunders R, Paton N, Fisher M, Rietmeijer C; SMART Study Group and INSIGHT. Burman W, et al. J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):142-50. doi: 10.1097/QAI.0b013e318183a9ad. J Acquir Immune Defic Syndr. 2008. PMID: 18769356 Free PMC article. Clinical Trial.

6

Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia.

Burman WJ, Cohn DL, Reves RR, Wilson ML. Burman WJ, et al. Clin Infect Dis. 1995 Mar;20(3):564-70. doi: 10.1093/clinids/20.3.564. Clin Infect Dis. 1995. PMID: 7756476 Review.

7

Short-term incarceration for the management of noncompliance with tuberculosis treatment.

Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Burman WJ, et al. Chest. 1997 Jul;112(1):57-62. doi: 10.1378/chest.112.1.57. Chest. 1997. PMID: 9228358

8

A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis.

Burman WJ, Dalton CB, Cohn DL, Butler JR, Reves RR. Burman WJ, et al. Chest. 1997 Jul;112(1):63-70. doi: 10.1378/chest.112.1.63. Chest. 1997. PMID: 9228359

9

A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.

Burman WJ, Reves RR, Rietmeijer CA, Cohn DL. Burman WJ, et al. Int J Tuberc Lung Dis. 1997 Apr;1(2):163-9. Int J Tuberc Lung Dis. 1997. PMID: 9441082

10

Evaluation of a disk diffusion method for determining susceptibility of Mycobacterium avium complex to clarithromycin.

Jarboe E, Stone BL, Burman WJ, Wallace RJ Jr, Brown BA, Reves RR, Wilson ML. Jarboe E, et al. Among authors: burman wj. Diagn Microbiol Infect Dis. 1998 Mar;30(3):197-203. doi: 10.1016/s0732-8893(97)00241-1. Diagn Microbiol Infect Dis. 1998. PMID: 9572027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters